Efficacy and safety of 4 months of treatment with esketamine nasal spray monotherapy in adult patients with treatment resistant depression

Neuroscience Applied 2026 Open access

Read full text

Authors: A. Cutler, D.J. Fu, I. Turkoz, M. Himedan, O. Lopena, L. Lim, Y. Kambarov, J. Verbanac

DOI: 10.1016/j.nsa.2025.106786

Cited by: 0

Fields of Study & Subjects

Treatment of Major Depression Anxiety Depression Psychometrics Treatment Cognitive Processes Psychedelics and Drug Studies